Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Nanosonics Limited ( (AU:NAN) ).
Nanosonics Limited, a healthcare technology firm listed on the ASX under code NAN, develops and supplies infection prevention solutions used in medical and clinical environments. Its ordinary fully paid shares form the basis of the company’s capital structure and are the subject of an ongoing on-market share buy-back.
The company reported that, as part of its on-market buy-back program first notified in December 2025, it has repurchased a total of 4,244,162 shares prior to the latest trading day, with a further 150,000 shares bought back on the previous day. The continued daily execution of the buy-back indicates active capital management, which can support earnings per share and may signal confidence in the company’s valuation to investors.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is an Australian-listed company trading under the ASX code NAN, with ordinary fully paid shares on issue. The company operates in the healthcare technology sector, focusing on infection prevention solutions for medical environments and related clinical settings.
Average Trading Volume: 756,798
Technical Sentiment Signal: Sell
Current Market Cap: A$1.12B
For a thorough assessment of NAN stock, go to TipRanks’ Stock Analysis page.